Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.

Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.

Item
http://www.wikidata.org/entity/Q33879440
Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-AnalysisRecombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.WEDGE: an anticoagulant thrombin mutant produced by autoactivation.Allostery in trypsin-like proteases suggests new therapeutic strategies.Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsisReview of optical coherence tomography based angiography in neuroscience.Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.Rational Design of Protein C Activators.Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice.Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice.Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis.
P2860

Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.

Item
http://www.wikidata.org/entity/Q33879440
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Thrombin mutant W215A/E217A tr ...... ouse model of ischemic stroke.
@ast
Thrombin mutant W215A/E217A tr ...... ouse model of ischemic stroke.
@en
type
label
Thrombin mutant W215A/E217A tr ...... ouse model of ischemic stroke.
@ast
Thrombin mutant W215A/E217A tr ...... ouse model of ischemic stroke.
@en
prefLabel
Thrombin mutant W215A/E217A tr ...... ouse model of ischemic stroke.
@ast
Thrombin mutant W215A/E217A tr ...... ouse model of ischemic stroke.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Thrombin mutant W215A/E217A tr ...... ouse model of ischemic stroke.
@en
P2093
P2860
P304
P31
P356
10.1161/STROKEAHA.110.603811
P407
P433
P478
P577
P5875
P698
P932